免疫检查点LAG-3与其配体结合机制的研究进展
摘要
关键词
全文:
PDF参考
[1]VISAN, IOANA. New ligand for LAG-3[J]. Nature reviews neuroscience,2019,20(2):111.[2]WENJIE ZHAI, XIUMAN ZHOU, HONGFEI WANG, et al. A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8 + T cell responses[J]. 药学学报(英文版),2020,10(6):1047-1060.[3]钟雪锋,WANG TONGMIN. LAG-3 在肿瘤免疫治疗中的研究进展[J]. 重庆医学,2022,51(22):3943-3947.[4]XU,F., LIU,J., LIU,D., et al. LSECtin expressed on melanoma cells promotes tumor progression by inhibiting antitumor T-cell responses[J]. Cancer research: The official organ of the American Association for Cancer Research, Inc,2014,74(13):3418-3428[5]CAMISASCHI,C., DEFILIPPO,A., BERETTA,V., et al. Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: Involvement of LAG-3[J]. The Journal of Investigative Dermatology,2014,134(7):1893-1902.
DOI: http://dx.doi.org/10.12361/2661-3603-05-23-152448
Refbacks
- 当前没有refback。